Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Dose Escalation Trial of Oral PXD101 in Patients With Advanced Solid Tumors

NCT00413075 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00413075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Dose Escalation Trial of Oral PXD101 in Patients With Advanced Solid Tumors
Lead sponsor
Valerio Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2006
Completion date
August 31, 2011
Enrollment
121 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, solid tumor